vs
BICYCLE THERAPEUTICS PLC（BCYC）与REDWOOD TRUST INC（RWT）财务数据对比。点击上方公司名可切换其他公司
BICYCLE THERAPEUTICS PLC的季度营收约是REDWOOD TRUST INC的1.8倍（$48.0M vs $25.9M），REDWOOD TRUST INC净利率更高（77.2% vs -42.0%，领先119.3%），BICYCLE THERAPEUTICS PLC同比增速更快（1193.3% vs -6.1%），过去两年BICYCLE THERAPEUTICS PLC的营收复合增速更高（56.7% vs -41.0%）
Bicycle Therapeutics是一家临床阶段生物制药企业，专注于开发双环肽类创新疗法以解决未被满足的医疗需求，核心管线覆盖肿瘤、罕见病与免疫疾病领域，在欧美布局运营，与全球头部药企达成战略合作推进候选药物落地。
Redwood Trust Inc是总部位于美国的专业房地产投资信托公司，主营住宅与商业抵押贷款、抵押贷款支持证券及房地产信贷类资产的投资管理，核心业务覆盖住宅抵押贷款发放、商业地产信贷和投资服务，客户以机构投资者和房地产市场参与者为主。
BCYC vs RWT — 直观对比
营收规模更大
BCYC
是对方的1.8倍
$25.9M
营收增速更快
BCYC
高出1199.4%
-6.1%
净利率更高
RWT
高出119.3%
-42.0%
两年增速更快
BCYC
近两年复合增速
-41.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $48.0M | $25.9M |
| 净利润 | $-20.2M | $20.0M |
| 毛利率 | — | — |
| 营业利润率 | -51.5% | — |
| 净利率 | -42.0% | 77.2% |
| 营收同比 | 1193.3% | -6.1% |
| 净利润同比 | 61.1% | 402.6% |
| 每股收益（稀释后） | $-0.29 | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCYCRWT
| Q4 25 | $48.0M | $25.9M | ||
| Q3 25 | $11.7M | $15.0M | ||
| Q2 25 | $2.9M | $13.8M | ||
| Q1 25 | $10.0M | $27.9M | ||
| Q4 24 | $3.7M | $27.6M | ||
| Q3 24 | $2.7M | $25.5M | ||
| Q2 24 | $9.4M | $67.4M | ||
| Q1 24 | $19.5M | $74.5M |
净利润BCYCRWT
| Q4 25 | $-20.2M | $20.0M | ||
| Q3 25 | $-59.1M | $-7.7M | ||
| Q2 25 | $-79.0M | $-98.5M | ||
| Q1 25 | $-60.8M | $16.1M | ||
| Q4 24 | — | $-6.6M | ||
| Q3 24 | $-50.8M | $14.8M | ||
| Q2 24 | $-39.8M | $15.5M | ||
| Q1 24 | $-26.6M | $30.3M |
营业利润率BCYCRWT
| Q4 25 | -51.5% | — | ||
| Q3 25 | -558.6% | -9.0% | ||
| Q2 25 | -2965.8% | -679.0% | ||
| Q1 25 | -703.7% | 80.2% | ||
| Q4 24 | — | -1.3% | ||
| Q3 24 | -2385.9% | 86.1% | ||
| Q2 24 | -498.3% | 30.3% | ||
| Q1 24 | -162.4% | 41.3% |
净利率BCYCRWT
| Q4 25 | -42.0% | 77.2% | ||
| Q3 25 | -503.7% | -51.4% | ||
| Q2 25 | -2703.8% | -712.0% | ||
| Q1 25 | -608.9% | 57.8% | ||
| Q4 24 | — | -24.0% | ||
| Q3 24 | -1898.4% | 58.1% | ||
| Q2 24 | -425.3% | 23.0% | ||
| Q1 24 | -136.0% | 40.6% |
每股收益（稀释后）BCYCRWT
| Q4 25 | $-0.29 | $0.11 | ||
| Q3 25 | $-0.85 | $-0.08 | ||
| Q2 25 | $-1.14 | $-0.76 | ||
| Q1 25 | $-0.88 | $0.10 | ||
| Q4 24 | — | $-0.08 | ||
| Q3 24 | $-0.74 | $0.09 | ||
| Q2 24 | $-0.77 | $0.10 | ||
| Q1 24 | $-0.62 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $628.1M | $255.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $610.0M | $982.6M |
| 总资产 | $717.6M | $23.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BCYCRWT
| Q4 25 | $628.1M | $255.7M | ||
| Q3 25 | $648.3M | $226.3M | ||
| Q2 25 | $721.5M | $302.0M | ||
| Q1 25 | $793.0M | $259.9M | ||
| Q4 24 | $879.5M | $245.2M | ||
| Q3 24 | $890.9M | $253.7M | ||
| Q2 24 | $961.4M | $275.6M | ||
| Q1 24 | $457.0M | $275.4M |
总债务BCYCRWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $30.9M | — | ||
| Q1 24 | $30.8M | $1.7B |
股东权益BCYCRWT
| Q4 25 | $610.0M | $982.6M | ||
| Q3 25 | $618.5M | $999.0M | ||
| Q2 25 | $668.9M | $1.1B | ||
| Q1 25 | $740.3M | $1.2B | ||
| Q4 24 | $793.1M | $1.2B | ||
| Q3 24 | $831.0M | $1.2B | ||
| Q2 24 | $873.8M | $1.2B | ||
| Q1 24 | $356.0M | $1.2B |
总资产BCYCRWT
| Q4 25 | $717.6M | $23.7B | ||
| Q3 25 | $764.0M | $22.6B | ||
| Q2 25 | $832.2M | $21.3B | ||
| Q1 25 | $883.9M | $19.9B | ||
| Q4 24 | $956.9M | $18.3B | ||
| Q3 24 | $996.7M | $18.4B | ||
| Q2 24 | $1.1B | $16.5B | ||
| Q1 24 | $547.1M | $15.1B |
负债/权益比BCYCRWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.04× | — | ||
| Q1 24 | 0.09× | 1.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.3M | $-10.1B |
| 自由现金流经营现金流 - 资本支出 | $-19.9M | — |
| 自由现金流率自由现金流/营收 | -41.5% | — |
| 资本支出强度资本支出/营收 | 1.2% | — |
| 现金转化率经营现金流/净利润 | — | -504.15× |
| 过去12个月自由现金流最近4个季度 | $-252.0M | — |
8季度趋势，按日历期对齐
经营现金流BCYCRWT
| Q4 25 | $-19.3M | $-10.1B | ||
| Q3 25 | $-71.2M | $-2.7B | ||
| Q2 25 | $-72.8M | $-2.1B | ||
| Q1 25 | $-86.4M | $-2.0B | ||
| Q4 24 | $-164.7M | $-5.9B | ||
| Q3 24 | $-39.8M | $-2.1B | ||
| Q2 24 | $-44.6M | $-2.0B | ||
| Q1 24 | $-70.9M | $-954.2M |
自由现金流BCYCRWT
| Q4 25 | $-19.9M | — | ||
| Q3 25 | $-71.8M | — | ||
| Q2 25 | $-73.3M | — | ||
| Q1 25 | $-87.0M | — | ||
| Q4 24 | $-166.0M | — | ||
| Q3 24 | $-40.3M | — | ||
| Q2 24 | $-45.0M | — | ||
| Q1 24 | $-70.9M | — |
自由现金流率BCYCRWT
| Q4 25 | -41.5% | — | ||
| Q3 25 | -612.3% | — | ||
| Q2 25 | -2509.7% | — | ||
| Q1 25 | -871.7% | — | ||
| Q4 24 | -4475.7% | — | ||
| Q3 24 | -1504.7% | — | ||
| Q2 24 | -481.2% | — | ||
| Q1 24 | -362.9% | — |
资本支出强度BCYCRWT
| Q4 25 | 1.2% | — | ||
| Q3 25 | 5.7% | — | ||
| Q2 25 | 17.1% | — | ||
| Q1 25 | 6.1% | — | ||
| Q4 24 | 33.3% | — | ||
| Q3 24 | 16.3% | — | ||
| Q2 24 | 4.5% | — | ||
| Q1 24 | 0.1% | — |
现金转化率BCYCRWT
| Q4 25 | — | -504.15× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -120.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -140.86× | ||
| Q2 24 | — | -126.56× | ||
| Q1 24 | — | -31.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
